Wai Yuen Tong Medicine Holdings (HKSE:00897) Total Liabilities : HK$3,098 Mil (As of Sep. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Wai Yuen Tong Medicine Holdings Total Liabilities?

Wai Yuen Tong Medicine Holdings's Total Liabilities for the quarter that ended in Sep. 2023 was HK$3,098 Mil.

Wai Yuen Tong Medicine Holdings's quarterly Total Liabilities declined from Sep. 2022 (HK$3,383.91 Mil) to Mar. 2023 (HK$3,325.43 Mil) and declined from Mar. 2023 (HK$3,325.43 Mil) to Sep. 2023 (HK$3,098.23 Mil).

Wai Yuen Tong Medicine Holdings's annual Total Liabilities declined from Mar. 2021 (HK$4,014.18 Mil) to Mar. 2022 (HK$3,637.10 Mil) and declined from Mar. 2022 (HK$3,637.10 Mil) to Mar. 2023 (HK$3,325.43 Mil).

Wai Yuen Tong Medicine Holdings Total Liabilities Historical Data

The historical data trend for Wai Yuen Tong Medicine Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wai Yuen Tong Medicine Holdings Total Liabilities Chart

Wai Yuen Tong Medicine Holdings Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Liabilities

Get a 7-Day Free Trial

1,006.58

3,736.80

4,014.18

3,637.10

3,325.43

Wai Yuen Tong Medicine Holdings Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Total Liabilities	Get a 7-Day Free Trial															3,993.69	3,637.10	3,383.91	3,325.43	3,098.23

Wai Yuen Tong Medicine Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Wai Yuen Tong Medicine Holdings's Total Liabilities for the fiscal year that ended in Mar. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1657.188	+	(1032.461	+	635.782
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	3,325

Total Liabilities	=	Total Assets (A: Mar. 2023 )	-	Total Equity (A: Mar. 2023 )
	=	7013.815	-	3688.384
	=	3,325

Wai Yuen Tong Medicine Holdings's Total Liabilities for the quarter that ended in Sep. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1615.96	+	(877.709	+	604.557
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	3,098

Total Liabilities	=	Total Assets (Q: Sep. 2023 )	-	Total Equity (Q: Sep. 2023 )
	=	6583.962	-	3485.736
	=	3,098

Wai Yuen Tong Medicine Holdings Total Liabilities Related Terms

Thank you for viewing the detailed overview of Wai Yuen Tong Medicine Holdings's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Wai Yuen Tong Medicine Holdings (HKSE:00897) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wai Yuen Tong Medicine Holdings Ltd (HKSE:00897) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

39 Wang Kwong Road, Suite 3101, 31st Floor, Skyline Tower, Kowloon Bay, Kowloon, Hong Kong, HKG

Website

https://www.wyth.net

Wai Yuen Tong Medicine Holdings Ltd is an investment holding company. The company's operating segment includes production and sale of Chinese pharmaceutical and health food products; production and sale of Western pharmaceutical and health food products and property investment and management and sale of properties in the agricultural produce market. It generates maximum revenue from the production and sale of Chinese pharmaceutical and health food products which include manufacturing, processing, and sale of traditional Chinese medicine which includes Chinese medicinal products sold under the brand name Wai Yuen Tong. Geographically, it derives a majority of revenue from Mainland China.

Executives

Wang On Group Limited	2501 Other
Tang Ching Ho	2501 Other
Yau Yuk Yin	2202 Interest of your spouse

Wai Yuen Tong Medicine Holdings (HKSE:00897) Headlines

No Headlines